AFP and hepatocellular carcinoma: Moreover, an immediate pretransplant AFP > 400 ng/mL in BM patients is considered a crucial factor for post-transplant recurrence within 5 years after LDLT and RFS in patients with very large HCC (≥7 cm) as well.